Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Cooling method and device for cooling a medium-voltage electrical installation in a protective sheath
Mounting structure, electro-optical apparatus, and touch panel
Baseball player stationery tab
Peer-to-peer, internet protocol telephone system with proxy interface for configuration data
Carrier sense multiple access (CSMA) protocols for power line communications (PLC)
5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
Architecture for accelerated computer processing
  Randomly Featured Patents
Webbing system
Pure water manufacturing apparatus
Headgear suspension system
Field controlled permanent magnet brushless electric machine
Self-centering pull-out light tube assembly
Optical fiber composite insulator
Process for regenerating waste oils of synthetic lubricants containing fluorine atom
Tracking cart system
Light measuring device for a camera
Spring loaded swinging door system